Clinical Trial

Coenzyme Q10 in Pediatric Community-Acquired Pneumonia

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 5, 2026 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The aim of this work is to assess the benefit of coenzyme Q10 supplementation, in addition to standard antibiotic and other supportive therapy, in the management of hospitalized children with community acquired pneumonia
Trial Details
NCT Number NCT07317440
Lead Sponsor Tanta University
Conditions Community Acquired Pneumonia
Enrollment 120 participants
Start Date 2025-12-31
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-05